Status:
COMPLETED
Airway Clearance by Fiberoptic Bronchoscopy in Bronchiectasis Followed by Gentamicin and Dexamethason Injection
Lead Sponsor:
Alexandria University
Conditions:
Bronchiectasis Adult
Bronchiectasis With Acute Exacerbation
Eligibility:
All Genders
Phase:
NA
Brief Summary
Fiberoptic Bronchoscopic Removal of Secretions and Antibiotic Injection
Detailed Description
fiberoptic bronchoscopic injection of dexamethason and gentamicin after airway clearance
Eligibility Criteria
Inclusion
- 1- Adult subjects. 2- Male and female subjects are enrolled. 3- patients with NCFB confirmed by chest high-resolution computed tomography (HRCT) 4- patients needing antibiotic treatment at the hospital due to exacerbation 5- Patients who underwent AC by bronchoscopy at the hospital.
- \-
Exclusion
- 1- Uncooperative subjects. 2- Unwilling to participate. 3- Inability to lie on the back with raised arms over the head for HRCT. 4- Presence of cystic pulmonary fibrosis; 5- Patients with active pulmonary tuberculosis; 6- Those awaiting surgery; 7- Patients who underwent interventional therapy for hemoptysis; those with allergic bronchopulmonary aspergillosis (ABPA); 8- Patients who did not undergo bronchoscopy for different reasons or combined with lung cancer.
- \-
Key Trial Info
Start Date :
November 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06906354
Start Date
November 11 2024
End Date
January 20 2025
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chest Department -Faculty of Medicine
Alexandria, Egypt, Egypt, 11511